Breast cancer vaccines
Abstract
The objective of this study was to review issues involved in the search for a breast cancer vaccine. A review of the recent literature (2004–2007) was undertaken, with earlier literature included as appropriate for background, to assess 1) current approaches being used to create a therapeutic breast cancer vaccine, and 2) potential strategies for a preventive vaccine targeting either an infectious agent or tumor‐associated antigen. Several approaches to the development of a therapeutic vaccine show promise, including tumor cell/dendritic cell fusion and DNA vaccines based on single purified antigens or DNA fragments from whole cells. Most of these experimental vaccines have either not moved beyond preclinical testing or have not shown a significant clinical response. Strategies involving host factors that mitigate immune response against tumors also show promise. Interest has increased in developing a preventive vaccine that can be administered to immunocompetent patients with minimal or no evidence of disease. Prophylactic vaccines typically target infectious agents, but the evidence for an infectious etiology for breast cancer is largely descriptive and difficult to interpret. A second strategy for a preventive breast cancer vaccine is to target tumor‐associated antigens. Ongoing clinical trials are utilizing this approach, with preliminary results that are encouraging. Cancer 2007. © 2007 American Cancer Society.Keywords
This publication has 49 references indexed in Scilit:
- Breast cancer vaccines: maximizing peptide-based vaccines by regulatory T cell depletion and toll-like receptor 9 activationBMC Cancer, 2007
- Defining the Ability of Cyclophosphamide Preconditioning to Enhance the Antigen-specific CD8+ T-cell Response to Peptide Vaccination: Creation of a Beneficial Host Microenvironment Involving Type I IFNs and Myeloid CellsJournal of Immunotherapy, 2007
- CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cellsJournal of Clinical Investigation, 2006
- Prophylactic human papillomavirus vaccinesJournal of Clinical Investigation, 2006
- The B7-H1 (PD-L1) T Lymphocyte-Inhibitory Molecule Is Expressed in Breast Cancer Patients with Infiltrating Ductal Carcinoma: Correlation with Important High-Risk Prognostic FactorsNeoplasia, 2006
- The global health burden of infection‐associated cancers in the year 2002International Journal of Cancer, 2006
- Vaccination for LeukemiaTransplantation and Cellular Therapy, 2006
- Fusion Cell Vaccination of Patients with Metastatic Breast and Renal Cancer Induces Immunological and Clinical ResponsesClinical Cancer Research, 2004
- Heterologous Protection Against Influenza by Injection of DNA Encoding a Viral ProteinScience, 1993
- Contrasting effects of cyclophosphamide and prednisolone on the phenotype of human peripheral blood leukocytesClinical Immunology and Immunopathology, 1983